Author:
Ali Nur Hasanah,Hamzah Nur Asyiqin Amir,Saad Norhashimah Mohd,Mahfooz Rania,Abdullah Abdul Rahim
Publisher
Atlantis Press International BV
Reference18 articles.
1. U. Galicia-Garcia et al., “Pathophysiology of type 2 diabetes mellitus,” Int. J. Mol. Sci., vol. 21, no. 17, pp. 1–34, 2020, doi: https://doi.org/10.3390/ijms21176275.
2. S. I. Taylor, Z. S. Yazdi, and A. L. Beitelshees, “Pharmacological treatment of hyperglycemia in type 2 diabetes,” J. Clin. Invest., vol. 131, no. 2, pp. 1–14, 2021, doi: https://doi.org/10.1172/JCI142243.
3. S. Tsalamandris et al., “The role of inflammation in diabetes: Current concepts and future perspectives,” Eur. Cardiol. Rev. , vol. 14, no. 1, pp. 50–59, 2019, doi: https://doi.org/10.15420/ecr.2018.33.1.
4. L. S. Francesca Pivari, Alessandra Mingione, Caterina Brasacchio, “Curcumin and Type 2 Diabetes Mellitus: Prevention and Treatment,” Nutrients, vol. 31, no. August, pp. 10–25, 2019.
5. Professor Rhys Williams, International Diabetes Federation, vol. 102, no. 2. 2021. doi: https://doi.org/10.1016/j.diabres.2013.10.013.